Norovirus-Binding Peptides for Simple High-Specificity Detection
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for detecting norovirus, such as RNA amplification and antibody-based detection, are complex, time-consuming, costly, and have low specificity and stability issues, necessitating a more effective and simpler detection method and prophylactic/therapeutic approach.
Innovation Solution
Development of norovirus-binding peptides with high affinity, composed of specific amino acid sequences, which can be used for sensitive detection and infection control through immunoassays like ELISA, and potentially as therapeutic agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Measurement precision
If RNA amplification method is used for norovirus detection, then detection sensitivity is improved, but operation complexity and time consumption increase
Solution Approach 1:
The invention extracts and utilizes only the essential binding function from the complex RNA amplification process by employing peptide-norovirus complexes that directly bind to norovirus particles. This extraction of the core detection capability eliminates the need for reverse transcription and amplification steps, thereby reducing operational complexity while maintaining detection sensitivity through specific peptide-norovirus binding.
Solution Approach 2:
The peptide-norovirus complex serves as an intermediary that directly binds to norovirus particles, replacing the complex enzymatic amplification process. This intermediary approach allows for simplified detection procedures while maintaining high sensitivity through the specific and strong binding affinity of the peptide complex for norovirus.
2Measurement precision
If antibody-based detection is used for norovirus, then detection capability is achieved, but manufacturing cost and quality stability deteriorate
Solution Approach 1:
The invention replaces expensive, biologically-produced antibodies with chemically-synthesized peptide complexes that are more cost-effective to manufacture. These peptide-norovirus complexes can be produced through chemical synthesis rather than requiring animal or cell culture systems, significantly reducing manufacturing costs while maintaining stable quality and detection capability.
Solution Approach 2:
The invention changes the fundamental parameter of the detection reagent from biologically-produced antibodies to chemically-synthesized peptide complexes. This parameter change enables more consistent quality control, reduced manufacturing costs, and improved stability while preserving the essential detection capability for norovirus.
3Measurement precision
If previously reported norovirus peptide is used, then norovirus binding is achieved, but bonding strength is insufficient
Solution Approach 1:
The invention creates a composite peptide-norovirus complex with optimized amino acid sequences that enhance binding affinity. By designing peptides with specific sequences (such as those containing cysteine residues for disulfide bond formation) and combining them with norovirus particles, the complex achieves significantly stronger bonding strength compared to previously reported peptides, while maintaining specific norovirus binding capability.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The peptides enable specific and sensitive detection of norovirus and inhibit viral infection, offering a simpler, cost-effective alternative to existing methods.
Implementation Method 1
a norovirus-binding peptide having affinity to norovirus
Data Source
AI summary
Provided is a peptide that specifically binds to norovirus, which is useful for detection and infection control of norovirus. A norovirus-binding peptide consisting of an amino acid sequence selected from the group consisting of SEQ ID NOs: 1 to 185.